Here's why a gene therapy product originally developed at CHOP spinout Spark Therapeutics was shelved by Pfizer.
IFLScience on MSN45m
New Gene Therapy “Life Changing” For Kids With Severe Form Of Blindness"We have, for the first time, an effective treatment for the most severe form of childhood blindness, and a potential ...
Sensorion's Audiogene Phase I/II trial of the SENS-501 gene therapy programme has received a favourable recommendation from ...
Miltenyi Biotec launches India's first dedicated Cell and Gene Therapy Center of Excellence in Hyderabad, aiming to advance ...
Latus Bio, Inc. (Latus), a biotechnology company pioneering advances in AAV gene therapy, is pleased to announce data ...
Miltenyi Biotec opens cell & gene therapy centre in Genome Valley, advancing innovation in combating diseases like cancer.
12 years after going public, beleaguered gene therapy company bluebird bio will be sold to private equity groups Carlyle and ...
Beqvez was Pfizer's first gene therapy, stemming from an alliance with Spark Therapeutics (now part of Roche) more than a ...
Miltenyi Biotec launched India's first Cell and Gene Therapy Center in Hyderabad. The Miltenyi Innovation and Technology ...
In recent weeks, Children’s Hospital Los Angeles in East Hollywood has taken steps to improve care for some of its pediatric patients. In late January, ...
In a major breakthrough, four children born with severe visual impairments have experienced life-changing improvements in their ...
Entrada Therapeutics is finally able to get its Duchenne muscular dystrophy candidate (DMD) back on track after the FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback